Although we confirmed the effective role of the GCSRGs signature in predicting the prognosis of osteosarcoma patients and confirmed the tumor-promoting effect of TRAM2 in osteosarcoma cells in cytological experiments in vitro, this study still has certain drawbacks that require further research. The gene discussed is TRAM2; the disease is neoplasm.